Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Netanel Horowitz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Thrombophilia and cancerNetanel Horowitz, Benjamin Brenner
Blood Reviews|June 15, 2025
Novel therapies for acute myeloid leukemia. Does age still matter?Baher Krayem, Avraham Frisch, Netanel Horowitz
Cytometry. Part B, Clinical Cytometry|December 10, 2019
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10<sup>+</sup> diffuse large B-cell lymphoma and follicular lymphomaDavid Azoulay, Hector I Cohen, Eugene Dementiev, et al.
Bone Marrow Research|December 18, 2012
New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomibNetanel Horowitz, Ilana Oren, Noa Lavi, et al.
Case Reports in Rheumatology|June 14, 2016
Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with PolyangiitisMohammad E Naffaa, Alexander P Rozin, Netanel Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2016
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasisMarina Weissmann, Gil Arvatz, Netanel Horowitz, et al.
Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life StudyEfrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Thrombophilia and cancerNetanel Horowitz, Benjamin Brenner
Blood Reviews|June 15, 2025
Novel therapies for acute myeloid leukemia. Does age still matter?Baher Krayem, Avraham Frisch, Netanel Horowitz
Cytometry. Part B, Clinical Cytometry|December 10, 2019
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10<sup>+</sup> diffuse large B-cell lymphoma and follicular lymphomaDavid Azoulay, Hector I Cohen, Eugene Dementiev, et al.
Bone Marrow Research|December 18, 2012
New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomibNetanel Horowitz, Ilana Oren, Noa Lavi, et al.
Case Reports in Rheumatology|June 14, 2016
Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with PolyangiitisMohammad E Naffaa, Alexander P Rozin, Netanel Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2016
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasisMarina Weissmann, Gil Arvatz, Netanel Horowitz, et al.
Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life StudyEfrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Pageof 2